HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luciano Mutti Selected Research

51 C

7/2020HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luciano Mutti Research Topics

Disease

65Malignant Mesothelioma
05/2022 - 02/2002
64Neoplasms (Cancer)
05/2022 - 10/2002
34Mesothelioma
01/2022 - 02/2002
6Lung Neoplasms (Lung Cancer)
12/2021 - 09/2007
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 01/2020
5Carcinogenesis
12/2020 - 03/2010
4Rare Diseases (Rare Disease)
02/2020 - 06/2005
3Melanoma (Melanoma, Malignant)
01/2020 - 01/2015
3Genetic Predisposition to Disease (Genetic Predisposition)
07/2008 - 10/2002
2Disease Progression
12/2020 - 06/2009
2Breast Neoplasms (Breast Cancer)
12/2020 - 06/2016
2Inflammation (Inflammations)
11/2017 - 03/2016
2Neoplasm Metastasis (Metastasis)
11/2015 - 09/2009
2Pleural Effusion (Pleural Effusions)
03/2010 - 11/2002
1Adenocarcinoma of Lung
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Triple Negative Breast Neoplasms
12/2020
1COVID-19
07/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Osteosarcoma (Osteogenic Sarcoma)
01/2019
1Disease Resistance
11/2017
1Tics (Tic)
01/2017
1Hypoxia (Hypoxemia)
01/2017

Drug/Important Bio-Agent (IBA)

21AsbestosIBA
02/2020 - 10/2002
11MMEIBA
01/2021 - 11/2002
9Pharmaceutical PreparationsIBA
05/2022 - 05/2005
7MesothelinIBA
01/2017 - 09/2007
4Pemetrexed (MTA)FDA Link
01/2022 - 08/2007
4Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2007
4Immune Checkpoint InhibitorsIBA
11/2021 - 01/2020
4MicroRNAs (MicroRNA)IBA
01/2020 - 03/2010
4Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 01/2007
4Tumor Viral Antigens (Large T Antigen)IBA
07/2005 - 01/2003
3Estrogen ReceptorsIBA
12/2020 - 06/2009
3GemcitabineFDA Link
01/2019 - 08/2007
3tremelimumabIBA
01/2017 - 10/2013
3Peptides (Polypeptides)IBA
01/2017 - 07/2010
3Phosphotransferases (Kinase)IBA
11/2015 - 05/2005
3Estrogen Receptor betaIBA
01/2012 - 06/2009
2Bevacizumab (Avastin)FDA Link
01/2022 - 08/2017
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2012
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2002
2Long Noncoding RNAIBA
01/2022 - 01/2022
2Sirtuin 1IBA
12/2021 - 02/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 02/2002
2EnzymesIBA
12/2020 - 12/2009
2Messenger RNA (mRNA)IBA
12/2020 - 02/2010
2HLA-B Antigens (HLA-B)IBA
07/2020 - 01/2020
2Monoclonal AntibodiesIBA
01/2020 - 10/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 03/2016
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2017 - 01/2008
2Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2012
2Epidermal Growth Factor (EGF)IBA
01/2017 - 03/2010
2Small Interfering RNA (siRNA)IBA
11/2015 - 11/2012
2PolyphenolsIBA
12/2013 - 11/2012
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2013 - 11/2012
2Bortezomib (Velcade)FDA Link
01/2013 - 10/2007
2Gefitinib (Iressa)FDA Link
11/2010 - 03/2010
2Biological ProductsIBA
02/2010 - 06/2009
2ranpirnase (Pannon)IBA
12/2008 - 05/2005
1CaspasesIBA
05/2022
1alexidineIBA
05/2022
1abemaciclibIBA
01/2022
1Lysine (L-Lysine)FDA Link
12/2021
1Serine (L-Serine)FDA Link
12/2021
1Cyclin D1IBA
08/2021
1Circulating Tumor DNAIBA
05/2021
1Tumor Biomarkers (Tumor Markers)IBA
05/2021
1ProcalcitoninIBA
01/2021
1Adenosine Triphosphate (ATP)IBA
12/2020
1Protein Disulfide-IsomerasesIBA
12/2020
1HLA-A Antigens (HLA-A)IBA
07/2020
151 CIBA
07/2020
1HLA-C Antigens (HLA-C)IBA
07/2020
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2020
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2020
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2020
11-methyl-1-piperidinomethane sulfonateIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
15'-methylthioadenosineIBA
01/2020
1SirtuinsIBA
01/2019
1N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA
01/2019
1LCRF-0004IBA
01/2019
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
11/2017
1GlucocorticoidsIBA
11/2017
1Hormones (Hormone)IBA
11/2017
1Investigational DrugsIBA
08/2017
1Sorafenib (BAY 43-9006)FDA Link
01/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2017
1crenolanibIBA
01/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2017
1Atovaquone (Mepron)FDA Link
06/2016

Therapy/Procedure

28Therapeutics
05/2022 - 06/2005
9Drug Therapy (Chemotherapy)
01/2019 - 03/2008
8Immunotherapy
01/2022 - 10/2011
6Radiotherapy
01/2022 - 01/2017
1Salvage Therapy
02/2020